Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALK inhibitors(Anaplastic lymphoma kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 1 | US | 22 Jul 2022 | |
ALK positive Non-Small Cell Lung Cancer | IND Approval | CN | 13 Jun 2022 |